Abstract
Sarcomatous change has been rarely observed in hepatocellular carcinoma (HCC), but it is usually associated with very aggressive tumor behavior and widespread metastasis. To assess the impact of sarcomatous changes, we analyzed the outcomes of 15 patients with sarcomatous HCC after resection (n = 11) or liver transplantation (LT) (n = 4). No imaging findings characteristic of sarcomatous changes were observed. According to modified pathological tumor-node metastasis staging, the HCC lesions were classified as stage II in five patients, stage III in six, stage IVa2 in two, and stage IVb in one. The Milan criteria were met in 7 of 15 patients, including 3 of 4 in the LT group. R0 resection was achieved in 9 of 11 resected patients, and their 3-year overall and disease-free survival rates were both 18.2%. In the LT group, 3-year overall and disease-free survival rates were 37.5 and 25%, respectively. In patients within the Milan criteria, 2-year overall survival rate was 25% after resection and 33% after LT, showing no prognostic difference. Extrahepatic metastasis as initial recurrence was detected in 80% after resection and 66.7% after LT. In conclusion, we found that the prognosis of patients with sarcomatous HCC was very unfavorable after either resection or LT and that, except for liver biopsy, no diagnostic method could distinguish between sarcomatous and ordinary HCC. Vigorous postoperative systemic surveillance may be helpful for timely detection and treatment of localized metastases.
Similar content being viewed by others
Abbreviations
- CT:
-
computed tomography
- HCC:
-
hepatocellular carcinoma
- LT:
-
liver transplantation
- TACE:
-
transarterial chemoembolization
References
Kojiro M, Sugihara S, Kakizoe S, Nakashima O, Kiyomatsu K. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy. Cancer Chemother Pharmacol. 1989;23(Suppl):S4–S8.
Kakizoe S, Kojiro M, Nakashima T. Hepatocellular carcinoma with sarcomatous change. Clinicopathologic and immunohistochemical studies of 14 autopsy cases. Cancer. 1987;59:310–316.
Maeda T, Adachi E, Kajiyama K, Takenaka K, Sugimachi K, Tsuneyoshi M. Spindle cell hepatocellular carcinoma. A clinicopathologic and immunohistochemical analysis of 15 cases. Cancer. 1996;77:51–57.
Han JH, Park YN, Jung WH, Chi HS, Park C. A case with sarcomatoid hepatocellular carcinoma. Yonsei Med J. 1998;39:390–394.
Lee SG, Hwang S. How I do it: assessment of hepatic functional reserve for indication of hepatic resection. J Hepatobiliary Pancreat Surg. 2005;12:38–43.
American Liver Tumor Study Group. A randomized prospective multi-institutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. Investigator booklet and protocol, 1998.
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699.
Varma V, Cohen C. Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma. Adv Anat Pathol. 2004;11:239–249.
Oda Y, Katsuda S, Nakanishi I. An autopsy case of hepatic sarcomatoid tumor: immunohistochemical comparison with a sarcomatous component of hepatocellular carcinoma. Pathol Int. 1994;44:230–236.
Nishi H, Taguchi K, Asayama Y, Aishima S, Sugimachi K, Nawata H, et al. Sarcomatous hepatocellular carcinoma: a special reference to ordinary hepatocellular carcinoma. J Gastroenterol Hepatol. 2003;18:415–423.
Honda H, Hayashi T, Yoshida K, Takenaka K, Kaneko K, Fukuya T, et al. Hepatocellular carcinoma with sarcomatous change: characteristic findings of two-phased incremental CT. Abdom Imaging. 1996;21:37–40.
Hwang S, Lee SG, Moon DB, Ahn CS, Kim KH, Lee YJ, et al. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl. 2007;13:741–746.
Yamanaka J, Yamanaka N, Nakasho K, Tanaka T, Ando T, Yasui C, et al. Clinicopathologic analysis of stage II–III hepatocellular carcinoma showing early massive recurrence after liver resection. J Gastroenterol Hepatol. 2000;15:1192–1198.
Koda M, Maeda Y, Matsunaga Y, Mimura K, Murawaki Y, Horie Y. Hepatocellular carcinoma with sarcomatous change arising after radiofrequency ablation for well-differentiated hepatocellular carcinoma. Hepatol Res. 2003;27:163–167.
Komada N, Yamagata M, Komura K, Hayashi K, Maruyama T, Kataoka H, et al. Hepatocellular carcinoma with sarcomatous change arising in primary biliary cirrhosis. J Gastroenterol. 1997;32:95–101.
Eriguchi N, Aoyagi S, Okuda K, Hara M, Fukuda S, Tamae T, et al. Unusual liver carcinomas with sarcomatous features: analysis of four cases. Surg Today. 2001;31:530–533.
Idobe-Fujii Y, Ogi N, Hosho K, Koda M, Murawaki Y, Horie Y. Hepatocellular carcinoma with sarcomatous change arising after eradication of HCV via interferon therapy. Clin Imaging. 2006;30:416–419.
Yokomizo J, Cho A, Yamamoto H, Nagata M, Takiguchi N, Kainuma O, et al. Sarcomatous hepatocellular carcinoma without previous anticancer therapy. J Hepatobiliary Pancreat Surg. 2007;14:324–327.
Kishino T, Mori H, Nishikawa K, Ishiyama N, Yasui H, Sugiyama M, et al. Hepatocellular carcinoma containing sarcomatous lesions in a normal liver, accompanied by secondary Budd–Chiari syndrome. J Clin Gastroenterol. 2004;38:296–297.
Nam HS, Kim HK, Ma SU, Yu BH, Jung KM, Gong KT, et al. A case of sarcomatoid hepatocellular carcinoma in a young female without risk factor. Korean J Gastroenterol. 2006;47:458–462. (in Korean).
Pawlik TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, Choti MA. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg. 2007;245:435–442.
Morishita Y, Etori F, Sawada K, Kachi H, Yamada T, Kawamori T, et al. Sarcomatous hepatocellular carcinoma with malignant ascites. A report of two cases. Acta Cytol. 1998;42:759–764.
Tsujimoto M, Aozasa K, Nakajima Y, Kariya M. Hepatocellular carcinoma with sarcomatous proliferation showing an unusual and wide-spread metastasis. Acta Pathol Jpn. 1984;34:839–845.
Wanatabe J, Nakashima O, Kojiro M. Clinicopathologic study on lymph node metastasis of hepatocellular carcinoma: a retrospective study of 660 consecutive autopsy cases. Jpn J Clin Oncol. 1994;24:37–41.
Tsuji Y, Okada K, Fukuoka M, Watanabe Y, Ataka K, Minami R, et al. Hepatocellular carcinoma with a sarcomatous appearance: report of a case. Surg Today. 2001;31:735–739.
Lee SG, Hwang S, Jung JP, Lee YJ, Kim KH, Ahn CS. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Br J Surg. 2007;94:320–326.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hwang, S., Lee, SG., Lee, YJ. et al. Prognostic Impact of Sarcomatous Change of Hepatocellular Carcinoma in Patients Undergoing Liver Resection and Liver Transplantation. J Gastrointest Surg 12, 718–724 (2008). https://doi.org/10.1007/s11605-007-0393-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-007-0393-7